(AP) -- New Mexico Tech researchers have developed a sensor that uses the light-emitting properties of some nanoparticles to analyze and identify individual components of single strands of DNA and RNA.
Chemistry assistant professor Peng Zhang said team members hope they can refine the emerging technology and eventually adapt the tiny sensors to detect cancer cells in their early stages and to target and destroy cancerous cells and tissue.
"I am very excited about the potential for this new application, especially since the preliminary phase of this study has shown that we can identify cancer cells," Zhang said. "The next step will be to modify these nanoparticle sensors ... and actually kill cancer cells with them."
The nucleotide sensor design, described in a technical paper to be published in the Journal of the American Chemical Society, is versatile and easy to implement in DNA and RNA research studies and analyses in molecular biology, genetics and molecular medicine, the researchers said. The co-authors are Zhang, biology professor Snezna Rogelj and Tech students Khoi Nguyen and Damon Wheeler.
The sensor is based on a type of nanomaterial - materials that are microscopic - with unique "photon upconversion" properties.
Zhang said it "displays high sensitivity and specificity" - attributes that will be important in studying and treating many genetic-based diseases, such as sickle cell anemia.
© 2006 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Related stories:
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of
Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
New therapeutic treatment approach improves survival in esophageal cancer patients
A study released at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found that a new therapeutic treatment, when delivered endoscopically and used in combination with chemotherapy and radiation therapy, improved survival rates in patients with locally advanced esophageal cancer. Cancer of the esophagus often has a poor survival rate.
Landmark discovery of 'engine' that drives cell movement
This research by Thomas Leung, Ph.D., and his team in the GSK-IMCB Group at the Institute of Molecular and Cell Biology (IMCB), under Singapore's Agency for Science, Technology and Research, is fundamental to the understanding of how assembles its internal machinery required for cell movement.
Brazilian acai berry antioxidants absorbed by human body
A Brazilian palm berry, popular health food though little research has been done on it, now may have its purported benefits better understood. In the first research involving people, the acai (ah-sigh-EE) berry has proven its ability to be absorbed in the human body when consumed both as juice and pulp. That finding, by a team of Texas AgriLife Research scientists, was published in a recent issue of the
Journal of Agricultural and Food Chemistry.
Battling cancer, one cell at a time
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal
Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted.
Surface tension drives segregation within cell mixtures
What does a mixture of two different kinds of cells have in common with a mixture of oil and water? The same basic force causes both mixtures to separate into two distinct regions.
Nanoscopic screening process to speed drug discovery
Researchers at Wake Forest University are using nanotechnology to search for new cancer-fighting drugs through a process that could be up to 10,000 times faster than current methods.